Department of Radiation Oncology

Deep learning for brain metastasis detection and segmentation in longitudinal MRI data (2022) Huang Y, Bert C, Sommer P, Frey B, Gaipl U, Distel L, Weissmann T, et al. Journal article External Beam Accelerated Partial Breast Irradiation in Early Breast Cancer and the Risk for Radiogenic Pneumonitis (2022) Ott O, Stillkrieg W, Lambrecht U, Sauer TO, Schweizer C, Lamrani A, Strnad V, et al. Journal article Effects of Hippocampal Sparing Radiotherapy on Brain Microstructure—A Diffusion Tensor Imaging Analysis (2022) Dinkel J, Lahmer G, Mennecke A, Hock S, Richter-Schmidinger T, Fietkau R, Distel L, et al. Journal article Quality assurance of a breathing controlled four-dimensional computed tomography algorithm (2022) Szkitsak J, Karius A, Hofmann C, Fietkau R, Bert C, Speer S Journal article Elucidation of the Application of Blood Test Biomarkers to Predict Immune-Related Adverse Events in Atezolizumab-Treated NSCLC Patients Using Machine Learning Methods (2022) Zhou JG, Wong AHH, Wang H, Tan F, Chen X, Jin SH, He SS, et al. Journal article Patient-specific brain phantom SPECT database of cerebral perfusion analysed with the 3D-data analysis platform Scenium (2022) Grings A, Vija AH, Reymann M, Kuwert T, Brand J Conference contribution Pathologic response after induction chemo-immunotherapy with single or double immune checkpoint inhibition in locally advanced head and neck squamous cell carcinoma (HNSCC): Expansion cohorts of the CheckRad-CD8 trial. (2022) Hecht M, Eckstein M, Kallies A, Klautke G, Illmer T, von der Grün J, Laban S, et al. Conference contribution The Prognostic and Predictive Significance of Tumor-Infiltrating Memory T Cells Is Reversed in High-Risk HNSCC (2022) Hartan R, Schnellhardt S, Büttner-Herold M, Daniel C, Hartmann A, Fietkau R, Distel L Journal article Automation of Implant Reconstruction in Interstitial Brachytherapy of the Breast Using Electromagnetic Tracking (2022) Dürrbeck C, Fietkau R, Strnad V, Bert C Conference contribution Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial (2022) Goerling U, Gauler T, Dietz A, Grünwald V, Knipping S, Guntinas-Lichius O, Frickhofen N, et al. Journal article